Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity Against Influenza Virus

Vaccines - Switzerland
doi 10.3390/vaccines6040066
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Cellular Proteins in Influenza Virus Particles

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2008English

Vaccination With Dengue Virus-Like Particles Induces Humoral and Cellular Immune Responses in Mice

Virology Journal
VirologyInfectious Diseases
2011English

AuNP-M2e + sCpG Vaccination of Juvenile Mice Generates Lifelong Protective Immunity to Influenza a Virus Infection

Immunity and Ageing
AgingImmunology
2019English

Virus Like Particles as a Platform for Cancer Vaccine Development

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2017English

Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus

PLoS ONE
Multidisciplinary
2010English

Virus-Like Particles and Nanoparticles for Vaccine Development Against HCMV

Viruses
VirologyInfectious Diseases
2019English

Influenza Inactive Virus Vaccine With the Fusion Peptide (rTα1- BP5) Enhances Protection Against Influenza Through Humoral and Cell-Mediated Immunity

2016English

Co-Delivery of GPI-anchored CCL28 and Influenza HA in Chimeric Virus-Like Particles Induces Cross-Protective Immunity Against H3N2 Viruses

Journal of Controlled Release
Pharmaceutical Science
2016English

Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?

Frontiers in Immunology
AllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy